Quantification of Tumor Volume Changes During Radiotherapy for Non–Small-Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference24 articles.
1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non–small-cell lung cancer;Furuse;J Clin Oncol,1999
2. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III non small cell lung cancer: RTOG 9410;Curran;Proc Am Soc Clin Oncol,2003
3. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non–small-cell lung cancer: Phase II Southwest Oncology Group study S9504;Gandara;J Clin Oncol,2003
4. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309);Albain;J Clin Oncol,2005
5. Final results of a phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapy;Belderbos;Int J Radiat Oncol Biol Phys,2006
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adapt-On-Demand: A Novel Strategy for Personalized Adaptive Radiation Therapy for Locally Advanced Lung Cancer;Practical Radiation Oncology;2024-09
2. Adaptive Lung Radiation Therapy in the Era of Immunotherapy: A Single-Center Retrospective Study;Advances in Radiation Oncology;2024-01
3. CBCT-guided adaptive radiotherapy using self-supervised sequential domain adaptation with uncertainty estimation;Medical Image Analysis;2023-05
4. Scatter correction of 4D cone beam computed tomography to detect dosimetric effects due to anatomical changes in proton therapy for lung cancer;Medical Physics;2023-03-09
5. PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer;Pathology and Oncology Research;2022-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3